Browse studies

Find your next paid study

29 recruiting studies matching your filters

A Nonrandomized Trial Using DNA Liquid Biopsies to Guide Anticoagulation For Patients With Cancer-Associated Thromboembolism

The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likel…

Venous ThromboembolismDeep Venous Thrombosis

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07399977

Phase 2

Venous Thromboembolism Prevention in Outpatients With Glioma

This is an open label study of apixaban for venous thromboembolism prevention in patients with newly diagnosed grade 4 glioma.

GlioblastomaAstrocytomaVenous Thromboembolism

Estimated

~$10 – $6,250

University of Vermont Medical CenterNCT05683808

Observational

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recru…

Thromboembolism

Estimated

~$10 – $6,250

University of ArkansasNCT05301348

Phase 3

A Comparison of Anticoagulant Dosing Strategies to Reduce VTE and Mortality in Cancer Outpatients: A Randomized, Pragmatic Trial

Blood clots, also known as venous thromboembolism (VTE), are a common and serious complication for people with cancer. They can lead to pain, hospitalizations,…

CancerVTE (Venous Thromboembolism)

Estimated

~$10 – $6,250

University of VermontNCT07005024

FILTER - Filter Initial & Long Term Evaluation After Placement and Retrieval (Including Laser-Assisted Retrieval) Prospective Registry

A prospective data registry for all patients who undergo IVC (Inferior Vena Cava) filter placement or retrieval at Stanford. Potential enrollees will already b…

Venous Thromboembolism

Estimated

~$10 – $750

Stanford UniversityNCT01158482